Enzon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-58.6	-65.49	-5.36	13.51	2.53	-3.22
Depreciation & Amortization	18.14	19.29	23.68	25.22	27.3	27.99
Other Amortization	1.14	0.86	0.48	0.46	0.4	0.57
Loss (Gain) From Sale of Assets	16.99	16.99	0.11	0.11	0.31	0.01
Asset Writedown & Restructuring Costs	-12.1	-	0.45	0.34	0.03	0.5
Provision & Write-off of Bad Debts	0.29	0.29	0.2	0.18	0.19	0.28
Other Operating Activities	8.75	8.74	0.69	3.17	-0.34	-0.94
Change in Accounts Receivable	13.62	15.85	11.9	0.6	-8.8	2.93
Change in Inventory	14.1	11.76	0.37	-5.93	-13.02	-7.1
Change in Accounts Payable	-4.59	3.61	-8.02	0.48	9.11	1.26
Change in Other Net Operating Assets	-1.18	1.13	-21.13	6.03	-7.33	-19.06
Operating Cash Flow	-3.45	13	3.37	44.17	10.38	3.21
Operating Cash Flow Growth	-	285.81%	-92.37%	325.52%	222.93%	-90.41%
Capital Expenditures	-37	-35.36	-15.28	-14.47	-22.34	-17.23
Sale of Property, Plant & Equipment	-	-	-	0.01	0.15	0.01
Investing Cash Flow	-37	-35.36	-15.28	-14.46	-22.19	-17.23
Short-Term Debt Issued	-	-	21.5	10.1	14	13
Long-Term Debt Issued	-	9.76	-	-	-	-
Total Debt Issued	10.41	9.76	21.5	10.1	14	13
Short-Term Debt Repaid	-	-13.13	-	-30.24	-	-
Long-Term Debt Repaid	-	-	-11.25	-9.14	-7.51	-8.72
Total Debt Repaid	-16.86	-13.13	-11.25	-39.38	-7.51	-8.72
Net Debt Issued (Repaid)	-6.46	-3.37	10.25	-29.28	6.49	4.28
Issuance of Common Stock	30	30	-	-	-	-
Other Financing Activities	39.81	-0.85	-	-0.02	-0.29	-0.61
Financing Cash Flow	63.35	25.79	10.25	-29.29	6.19	3.68
Foreign Exchange Rate Adjustments	-0.04	0.09	-0.5	-1.33	4.52	4.36
Net Cash Flow	22.87	3.51	-2.16	-0.92	-1.09	-5.97
Free Cash Flow	-40.44	-22.37	-11.91	29.7	-11.96	-14.02
Free Cash Flow Margin	-11.34%	-6.14%	-2.95%	6.66%	-2.77%	-3.37%
Free Cash Flow Per Share	-0.30	-0.17	-0.12	0.29	-0.12	-0.14
Cash Interest Paid	9.7	9.7	10.34	11.42	7.43	5.22
Cash Income Tax Paid	1.75	1.75	2.48	4.06	7.32	4.18
Levered Free Cash Flow	-7.77	8.44	0.37	24.78	8.08	17.94
Unlevered Free Cash Flow	-2.81	13.65	6.78	31.83	12.95	21.22
Change in Working Capital	21.95	32.33	-16.88	1.18	-20.04	-21.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.